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Abstract
Background: Self-collection has been proposed as a strategy to increase cervical screening coverage among
hard-to-reach women. However, evaluations of the implementation of this strategy on a large scale are scarce. This
paper describes the process and measurement of the scaling-up of self-collection offered by community health
workers during home visits as a strategy to reach under-screened women aged 30+ with public health coverage,
defined as the target women.
Methods: We used an adaptation of the Health System Framework to analyze key drivers of scaling-up. A content
analysis approach was used to collect and analyze information from different sources. The RE-AIM (Reach,
Effectiveness, Adoption, Implementation, and Maintenance) model was used to evaluate the impact of the strategy.
Results: HPV self-collection was scaled-up in the province of Jujuy in 2014 after a RCT (Self-collection Modality Trial,
initials EMA in Spanish) was carried out locally in 2012 and demonstrated effectiveness of the strategy to increase
screening uptake. Facilitators of scaling-up were the organizational capacity of the provincial health system,
sustainable funding for HPV testing, and local consensus about the value of the technology. Reach: In 2014, 9%
(2983/33,245) of target women were screened through self-collection in the Jujuy public health sector.
Effectiveness: In 2014, 17% (n = 5657/33,245) of target women were screened with any HPV test (self-collected and
clinician-collected tests) vs. 11.7% (4579/38,981) in 2013, the pre-scaling-up period (p < 0.0001). Implementation:
Training about the strategy was provided to 84.2% (n = 609/723) of total community health workers (CHWs). Of 414
HPV+ women, 77.5% (n = 320) had follow-up procedures. Of 113 women with positive triage, 66.4% (n = 75) had
colposcopic diagnosis. Treatment was provided to 80.7% of CIN2+ women (n = 21/26). Adoption: Of trained CHWs,
69.3% (n = 422/609) had at least one woman with self-collection; 85.2% (n = 315/368) of CHWs who responded to
an evaluation survey were satisfied with self-collection strategy. Maintenance: During 2015, 100.0% (723/723) CHWs
were operational and 63.8% (461/723) had at least one woman with self-collection.
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Conclusions: The strategy was successfully scaled-up, with a high level of adoption among CHWs, which resulted
in increased screening among socially vulnerable under-screened women.
Keywords: Cervical cancer prevention, Self-collection HPV test, Argentina, Health System Framework,
Implementation research, RE-AIM Framework, Scaling-up
Background
A key component of cervical cancer prevention programs
is the achievement of high screening levels, particularly
among poor women with low access to the health system.
It is well known that human papillomavirus (HPV) testing
has important advantages over the Pap as a screening test:
high sensitivity (over 90%) [1] and high negative predictive
value [2]. Very importantly, through self-collection, HPV
testing can reduce barriers to screening and increase
coverage [3], especially among hard-to-reach women who
are at higher risk of cervical cancer [4]. The method is
highly accurate [5], acceptable to women, and effect-
ive to increase screening uptake [6–10]. However, this
evidence comes mainly from controlled research studies.
Although in the last years there has been an increasing
recognition of the importance of documentation and ana-
lysis of how scaling-up experiences are initiated, led, and
monitored [11], very little evidence exists about how
to scale-up HPV self-collection, potentially jeopardiz-
ing its successful integration into cervical cancer pre-
vention programs.
In 2012, self-collection was implemented in the province
of Jujuy as part of theEMA study (Self-collection Modality
Trial, initials EMA in Spanish), a mix-method research
study [9, 12, 13] that included a randomized controlled
trial (RCT) to evaluate effectiveness of HPV self-collection
offered by community health workers (CHWs) at home
visits to increase screening uptake [9]. The intervention
resulted in a fourfold increase in screening uptake
(from 20.2% to 85.9%), demonstrating that offering
the strategy was effective to improve cervical screen-
ing uptake [9]. Based on these findings, in 2014, self-
collection of HPV testing was scaled-up to the whole
province. The project was led by the National Cancer
Institute, Argentina, in collaboration with the Jujuy
Ministry of Health.
In this article, we report results of a study carried out to
evaluate the scaling-up of HPV self-collection using imple-
mentation research methods. For this, we used an adapta-
tion of the Health System Framework [14, 15] (HSF) and
the Reach, Effectiveness, Adoption, Implementation, and
Maintenance (RE-AIM) model for evaluation [16]. The spe-
cific aims of the study were to (1) identify key drivers of the
scaling-up of HPV self-collection; (2) evaluate if self-
collection was effective to increase screening uptake among
under-screened women when implemented on a larger
scale; (3) evaluate if the self-collection strategy was accepted
and adopted by CHWs; and (4) identify main
implementation barriers. Thus, the study provides evidence
about the scaling-up process that is key for countries




A detailed description on the context can be found
elsewhere [9, 17], but briefly in Argentina, the population
not covered by the social security sector (workers of the
informal economy and their families) has public health
coverage; health care is provided free of cost. Jujuy is
located in Northwest Argentina; 45.2% of population has
public health coverage [18]. Its public health system
includes a main hospital and 270 primary health care
(PHC) centers.
The PHC system employs more than 700 full-time
CHWs who visit around 110,000 households (70% of
total provincial households) [18] twice yearly for health-
related tasks including promotion of HPV testing at
health centers. Non-visited households are mainly those
located in middle-high and high income urban areas.
During the visits, CHWs collect socio-demographic and
health data of the household and its members, which is
used to annually update the PHC census.
A national screening information system (SITAM) [19]
registers data on screening tests and diagnostic proce-
dures from women attending opportunistically public
health centers, as there is no call and re-call system.
Scaling-up of self-collection was nested into the Jujuy
Demonstration Project (JDP) carried out between 2011
and 2014 (see Fig. 1) to evaluate the introduction of the
HPV test as the primary screening method for women
Fig. 1 Timeline of the Jujuy Demonstration Project
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aged 30+ attending public health services [17]. Cytology
is used as the triage test of HPV+ women.
The intervention
In Jujuy, in 2014, the strategy of self-collection offered by
CHWs during home visits was scaled-up for all women
with public health coverage and without a screening test
in the last 5 years (n = 33,245). To implement the strategy,
health authorities decided to involve all 723 CHWs
belonging to PHC system. The core components of the
intervention scaled-up included the offer of self-collection
during home visits by CHWs, sample handling and trans-
portation, follow-up of HPV+ women and treatment if
needed, and training of CHWs, as described below.
Target population
Target population were all women aged 30+ included in
the PHC census, not screened in the previous 5 years
(under-screened women) with public health coverage.
Offer of self-collection
Self-collection was offered by CHWs during home visits
throughout the second half of 2014. During the visit,
CHWs provided women with information about cervical
cancer prevention and HPV testing and then offered them
HPV self-collection, followed by a 10-min step-by-step
explanation on how to perform it using communication
support material (Additional file 1). Self-samples were
collected using the Qiagen cervical sampler during
the CHW visit. Pregnant women were not offered
self-collection.
Sample handling and transportation to PHC centers
CHWs labeled collectors with the woman name and the
national unique identifier number and transported speci-
mens at room temperature to PHC centers: from here
they were sent to the provincial HPV laboratory by the
health center. Samples were tested for 13 high-risk HPV
types using hybrid-capture 2, following manufacturer’s
instructions. Specimens were not processed if received
>14 days after collection, without liquid, brush, or identifi-
cation data (discarded samples).
Follow-up and treatment
According to guidelines [20], self-collected HPV+
women were referred to cytology triage. HPV+ women
with normal cytology were advised to repeat test at
18 months. Women with abnormal cytology (atypical
squamous cells of undetermined significance; atypical
cells cannot rule out high-grade squamous intraepithelial
lesion; high-grade squamous intraepithelial lesions; and
cancer) were referred to colposcopy, and biopsy if
needed. Biopsies were reported according to cervical
intraepithelial neoplasia (CIN) terminology. Identified
cases of CIN2+ were treated according to standard
protocols (loop electrosurgical excision procedure
(LEEP) for CIN). HPV-negative women were advised to
repeat screening within 5 years following national
recommendations.
Training of CHWs
From April to June 2014, national and provincial team
members led 18 workshops aimed at training of all 723
CHWs. Description of structure and content of workshops
are shown in Table 1. They included expert presentations,
discussions in small groups, and role playing to recreate dif-
ferent scenarios during the offer of self-collection. At the
end of each training workshop, CHWs were provided with
the list of women to be offered the test, self-collection kits,
and other materials needed for the offer (i.e., educational
materials). If needed, additional collectors/materials could
be requested to health centers or the provincial program
headquarters.
By the end of 2014, once the round of home visits was
finished, an evaluation workshop was carried out with
all CHWs. During this activity, CHWs were invited to
complete a self-administered questionnaire (SEAQ) to
elicit their views and opinions about the incorporation
of HPV self-collection as a programmatic activity. At the
beginning of 2015, a refresher training was provided to
all CHWs.




Information on the EMA study and scaling-up in a programmatic context
Cervical cancer Scientific data on cervical cancer and its relation with HPV
HPV testing Basic information on HPV testing as primary screening strategy for cervical cancer prevention
HPV self-collection HPV self-collection: clinician vs. self-collected tests, step-by-step self-collection take-up, self-collection results understanding, and
follow-up of HPV+ women
Communication
skills
Communication skills to conduct the educational talk (instruct women on how to perform self-collection)
Logistical
procedures
List of women to be offered self-collection, collectors, and training on sample labeling and transportation
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Evaluation of scaling-up
To answer the different questions addressed by the
study, we used a combination of methods:
1. Analysis of the scaling-up process. For this analysis,
we used an adaptation of the HSF [14, 15], which
includes contextual interconnected factors that are
considered key drivers for successful scaling-up [21].
The HSF integrates six functions, or building blocks
(service delivery, health workforce, information,
technology, funding, stewardship) that influence
system performance. We have re-configured and
simplified these functions to incorporate an
organizational dimension, which is a key factor for
cervical cancer prevention program effectiveness
[22]. Thus, this adaptation presents four dimensions
for analysis, instead of the original six, as service
delivery, health care workforce, and information
have been integrated into the dimension
organizational capacity, as follows (Fig. 2).
(a)Stewardship: Policy support; existence of policy
guidelines/norms that promote alignment with
strategic health goals; partnerships for
collaboration
(b)Organizational capacity: Capacity of the health
system to implement the intervention in all stages
of the screening/diagnoses/treatment continuum,
including facilities and health workforce; and
availability of health information systems
(c)Technology/strategy: Acceptability, effectiveness,
and consensus about the value of the technology/
strategy
(d)Funding: availability of sustainable funding
The analysis was based on content analysis of
program reports (information sheets, power point
presentations, etc.) and observation derived from
our participation in the policy definition. The
analysis was verified by triangulation across the
different sources. Also, preliminary results were
presented and discussed in a meeting of provincial
policy makers and health providers, as well as in the
final evaluation workshop, to discuss and verify
research findings.
2. Analyses of dimensions proposed by the RE-AIM
model [16, 23].
Reach
We measured the percentage of under-screened women
with public health coverage with self-collected tests/total
target population. Additionally, we compared target
women with HPV self-collection and the total target
population according to their age distribution using sim-
ple frequencies and percentages.
Effectiveness
We evaluated two outcomes: (1) The increase in screening
uptake among the target population. For this, we com-
pared the difference between the percentage of the target
population who was HPV-tested (both with self-collection
and clinician-collected tests at health centers)/total target
women in 2014 (post scale-up) and the percentage of the
target population screened at health centers/total target
women in 2013 (the year previous to self-collection intro-
duction). (2) The increase in the proportion of total
screened women who were from the target population.
For this, we compared the pre and post scaling-up
percentage of screened women who were from the target
Fig. 2 Health System Framework for analysis of cervical cancer prevention
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population/total screened women. Pre and post scaling-
up percentages were compared using chi-square tests
of association, and statistical significance was estab-
lished at p < 0.05.
Adoption
Three outcomes were measured: (1) percentage of adopters:
number of CHWs with at least one self-collected sample
registered in SITAM/total trained CHWs; (2) average num-
ber of women with self-collected tests per CHW; and (3)
percentage of CHWs satisfied with the self-collection
strategy/total CHWs who answered the SEAQ.
Implementation
Three outcomes were measured: (1) percentage of
trained CHWs/total CHWs; (2) percentage of CHWs
who reported at least one problem to obtain materials
(kits, leaflets)/total CHWs who answered the SEAQ; and
(3) percentage of discarded samples registered in lab
records/total number of self-collected tests.
Additionally, for this dimension, we analyzed follow-up
in the target population: (1) percentage of HPV+ women
with follow-up procedures, HPV+ women were consid-
ered to have received follow-up if they had at least one of
the following procedures, independently of the protocol
recommendation: cytology triage, colposcopy, or second
HPV negative test; (2) percentage of HPV+ women with
cytology triage (as per protocol); (3) percentage of women
with positive triage who had colposcopic diagnosis/total
women with positive triage; and (4) percentage of treated
women/women with CIN2+ lesions.
Maintenance
One outcome was measured: percentage of trained
CHWs with at least one self-collected sample registered
in SITAM in 2015/total trained CHWs.
Databases
Three databases were built specifically for the study. First,
we linked the 2013 PHC census to the SITAM database to
draw up the list of target women to be offered self-
collection. After field work, we linked the list of target
women to SITAM to extract data on HPV testing, triage,
diagnosis, and treatment, using each woman’s national
identity document number. To calculate the percentage of
screening uptake in 2013, we linked the 2012 list of target
population to the SITAM database. We also built a
specific database with CHWs information, including sex,
type of setting, and participation in training workshops.
Finally, we used the SEAQ to elicit CHWs views about
the offer of self-collection, specifically on their satisfaction
with the strategy, and problems during the implementa-
tion. CHWs were asked to fill the SEAQ during the final
evaluation workshop carried out at the end of the health
round. It was anonymous, and participation was volun-
tary; a member of the research team explained its objec-
tives and how to complete it.
Results
Results of the analysis based on the Health System
Framework are presented below.
Stewardship
The EMA study was a research project carried out colla-
boratively by national and provincial Ministries of Health
(MoHs). Expansion of the strategy was discussed by the
National Program of Cervical Cancer Prevention (NPCC)
with provincial authorities by the end of 2013 after results
from the EMA study were available. Scaling-up was consi-
dered key to reach provincial screening coverage objectives
[17]. A proposal was presented to and approved by the Ju-
juy Demonstration Project Scientific Advisory Committee
(Advisory Committee), which included members from
main medical scientific societies, international health orga-
nizations (Pan American Health Organization, Inter-
national Agency for Research on Cancer, and United
Nations Population Fund), and women organizations such
as the Women National Council. Thus, the decision to
scale-up was agreed in a context of high support by
national and provincial health authorities, and international
health organizations.
Next, core components and algorithm of the scaling-up
(described above) were defined on a national/provincial
management round-table. Their members met at least
twice during the implementation phase to monitor and
evaluate process results, as well as to identify emerging
problems. Introduction of HPV self-collection was incor-
porated into provincial norms and regulations, and
national protocols [20].
Organizational capacity
The organizational capacity of the province was consid-
ered adequate. Jujuy has a wide network of PHCs, and
CHWs visit houses twice a year as a regular, program-
matic activity. A referral network for triage, diagnosis,
and treatment was already in place, and health providers
had received training on HPV testing in the context of
the JDP initiated in 2011 [17]. The province runs the
first country public HPV laboratory, with more than
50,000 samples processed between 2012 and 2014. A
team of two navigators identifies women with abnormal
Pap smears to provide support in cases where women
have difficulties to complete diagnosis/treatment. How-
ever, no specific support is provided to HPV+ women
who need to be triaged. SITAM, the information system
for monitoring and evaluating screening activities [19],
was already in place, with registry of all women being
screened at public health institutions. SITAM was used
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to build the nominated list of target women to be of-
fered self-collection by CHWs.
Technology/strategy
Local evidence indicated that the strategy was both ac-
ceptable to women [9, 12] and CHWs [13], and effective
at increasing screening uptake [9], in agreement with
studies carried out in other countries and settings. Local
qualitative research carried out by our team had also
shown its high acceptability among provincial health pro-
fessionals, especially as a strategy to reach under-screened
women (Arrossi, unpublished observations). The Advisory
Committee also acknowledged the strong potential of
HPV self-collection to increase uptake although their
members expressed concern about its relatively lower de-
tection rate when compared to clinician-collected tests
[5]. As a result, the Advisory Committee strongly recom-
mended HPV self-collection to screen hard-to-reach
women. The Advisory Committee also discussed and
agreed on the proposed algorithm for HPV self-collection,
which implied a modification of the algorithm used in the
EMA RCT [9]. In effect, due to the relatively low perform-
ance of colposcopic diagnoses in the absence of a Pap
smear result found in that project (Arrossi, unpublished
observations), it was decided that HPV+ women would be
referred to cytology triage.
Funding of scaling-up
Funding of the scaling-up was evaluated as sustainable,
as it was implemented in the context of the JDP, with
funding by the national and provincial MoHs. The HPV
test was provided by the national MoH as part of the
JDP. In addition, the EMA study was carried out in a
programmatic context, with provincial health providers
and infrastructure funded through the regular budget.
Therefore, a decision was made by health authorities to
guarantee the funding needed to scale-up the strategy.
Triage, diagnosis, and treatment of HPV+ women were
provided by public health institutions, free of cost for
women, using the provincial referral network, which has
been described elsewhere [17]. Communication mate-
rials used for the offer of self-collection were those used
in the EMA RCT and provided to the province by the
NPCC, as part of the regular provision of communica-
tion materials by the national MoH to provinces. SITAM
is run and maintained by the national MoH.
RE-AIM measurement
Reach
In 2014, 2983 women from the target population (9%)
were screened with self-collected tests. Compared to the
target population (Table 2), more women with self-
collected tests were aged 35–44 (37.0 vs. 32.8%) and less
women were aged 65+ (4.6 vs. 8.7%).
Effectiveness
In 2014, 12,778 women aged 30+ were HPV-tested in
the Jujuy public health sector, 44.3% (n = 5657/12,778)
were target population, a 38% increase from 2013
(32.1%; n = 4579/14,272; p < 0.0001) (Table 3). Of the tar-
get population, 17.0% (n = 5657/33,245) were HPV-
tested with any HPV test (2983 with self-collected tests
and 2674 with clinician-collected tests at health centers).
This is a 45% increase in screening uptake of the tar-
get population relative to pre scale-up level in 2013
with clinician-collected tests at health centers (11.7%;
n = 4579/38,981; p < 0.0001).
Adoption
In total, 609/723 (84.2%) CHWs were trained; 69.3%
(n = 422/609) of them had at least one woman with a
self-collected sample registered in SITAM; 62.6% (n =
381/609) if only women from the target population
are considered (Table 3). The average number of
women with self-collected samples per CHW was 11
(range 1–74), and eight if only screening in the target
population is considered (range 1–31).
Of the 368 CHWs who completed the SEAQ, 85.6% of
(n = 315) mentioned that they were satisfied with the
self-collection strategy (Table 3).
Implementation
Training about the strategy was provided to 84.2% (n = 609)
of total CHWs (Table 3). When asked about problems dur-
ing implementation, 20.7% reported having at least one
problem to obtain collectors, leaflets, or materials needed
for the offer. Percentage of discarded samples at the labora-
tory was 0.9% (29/2983).
Adherence to follow-up, diagnosis, and treatment
Of the 2983 target women with self-collected tests, 414
(13.9%) were HPV+ (Fig. 3). Of these, 77.5% (n = 321) had
follow-up procedures: 282 (68.1%) had cytology triage, as
per protocol: 158 were normal, 99 abnormal and there
Table 2 REACH: Comparison of women with self-collected tests
with total target population, 2014
Target population with
self-collected test
Total target population p value
n % n %
Age
30–34 677 22.8 7827 23.5 p < 0.001
35–44 1105 37.0 10,908 32.8
45–54 615 20.6 6580 19.8
55–64 448 15.0 5033 15.2
65+ 138 4.6 2897 8.7
Total 2983 100.0 33,245 100.0
*Chi-square test, statistical significance was established at p < 0.05
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were no available results for 25; 14 had only colposcopy,
and 25 had a second negative HPV test. Total women
with colposcopic diagnosis were 75 (66.4% of women with
positive triage), including 14 colposcopies without
cytology result (34 normal, 35 abnormal; 6 women had
colposcopies at private services without available results).
Among women with abnormal colposcopy, 34 had biop-
sies performed at public health services and had results in
SITAM. Among them, 26 had CIN2+ (detection rate
0.9%, n = 26/2983); 21 of these (80.7%) received treatment
(follow-up until June 30, 2016).
Maintenance
In the second year of the scaling-up process (2015), 723
(100.0%) CHWs were operational: all 609 CHWs trained
in 2014 and 114 incorporated and trained in 2015. In
that year, 63.8% (461/723) had at least one woman with
a self-collected test registered in SITAM (Table 3).
Discussion
Increasing screening uptake among hard-to-reach women
is a major critical factor for cervical cancer control. Using
the RE-AIM model and the HSF, we analyzed the scaling-
up of HPV self-collection offered by CHWs at home visits,
in the province of Jujuy, Argentina. The strategy resulted
in a 45% increase in screening of under-screened, socially
vulnerable population. Results also showed that most
CHWs adopted the strategy, with few implementation
problems. Leadership and partnership of national and
local health decision makers, governmental funding, an
adequate organizational capacity of the health system, and
consensus about the potential value of the strategy were
identified as key drivers of the scaling-up.
This is, to our knowledge, the first study analyzing
scaling-up of a HPV self-collection strategy using imple-
mentation science methods. Utilization of the RE-AIM
framework allowed us to include in the analysis the five
factors that more completely characterize the public
health impact of an intervention carried out in real-world
environments [16]. In addition, the HSR framework guided
the evaluation to identify key drivers of the scaling-up
process. Thus, this study can serve as a model of how
implementation science can be used to plan, conduct, and
evaluate interventions that are implemented on a large
scale in programmatic, real-world contexts. Stewardship re-
fers to the policy environment in which the implementation
Table 3 RE-AIM measurement
RE-AIM dimension Question Outcome Value
Reach What are the characteristics of women
reached by the strategy?
Under-screened women with public health coverage
with self-collected test (2014)
9.0%
Effectiveness Is the strategy effective to increase
screening uptake in target population?
Screened women from target population,
post-intervention (2014)
44.3%
Screened women from target population,
pre-intervention (2013)
32.1%
Target population with screening uptake,
post-intervention (2014)
17.0%
Target population with screening uptake,
pre-intervention (2013)
11.7%
Adoption Is the self-collection strategy accepted
and adopted by CHWs?
CHWs with at least one self-collected test registered
in SITAM
69.3%
CHWs with at least one self-collected test in target
population registered in SITAM
62.6%
CHWs that mentioned that they were satisfied with
self-collection strategy
85.6%
Implementation To what extent the intervention was
implemented as intended?
Trained CHWs/total CHWs 84.2%
CHWs who reported at least one problem to obtain
materials
20.7%




HPV+ with follow-up procedures 77.5%
Triage + women with colposcopy 66.4%
Women with CIN2+ with registered treatment 80.7%
Maintenance (1 year) Is it possible to sustain the intervention
over time?
Trained CHWs with at least one self-collected test registered
in SITAM in 2015
63.8%
TP target population, CHWs community health workers
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of a health strategy is made possible, through three main
dimensions: formulating health policy, exerting influence,
and collecting and using intelligence [24]. In our study,
scaling-up of HPV self-collection as part of a national dem-
onstration project to introduce HPV testing as primary
screening [17] provided governmental stewardship in a
context of high policy support. This was reinforced by in-
volvement of the scientific community and other main
health and women organizations, which ensured alignment
of objectives and goals. Another key factor was that
scaling-up was based on the EMA study, a research project
carried out in a programmatic context and run collabora-
tively between the national and provincial health author-
ities. Incorporating research into implementation, country
ownership, and political will have been identified as factors
associated with faster diffusion of an innovation [25, 26]. By
making use of legal, regulatory, and policy instruments to
steer health system performance [24], stewardship bears a
strong relationship to the concept of regulation [27]. In our
study, inclusion of the strategy into national and provincial
norms and protocols was also identified as a key enhancer
of the scaling-up.
Integrating activities into existing health systems has
been identified in the literature as an important factor for
successful scaling-up [28]. In this case, expansion followed
the EMA study, using the provincial organizational
capacity. Health system weaknesses contributing to poor
health outcomes include poor management and a weak
PHC system [29]. In Jujuy, the PHC system is well
developed, with almost 700 CHWs visiting houses twice a
year. The health system included the network of diagnosis
and treatment units and the first public HPV laboratory of
the country. Lack of information systems is also a key
problem affecting cancer control programs [30]. The use
of SITAM allowed not only to closely monitor and
evaluate the scaling-up but also to build the target popu-
lation list, facilitating identification and contact with
under-screened women.
Fig. 3 Follow-up of HPV+ women among target population. Jujuy 2014
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Securing sustainable funding for large-scale implemen-
tation can be a major challenge. Many pilot or research
studies are funded by non-governmental national or inter-
national organizations, which results in funding very often
ending with the pilot study [31]. Also, interventions
proved efficacious in research studies carried out using
industry-donated technology might be difficult to scale-up
once the research is finished [32]. All funding for this pro-
ject was provided by the regular mechanisms of public
health system financing. Thus, scaling-up was guaranteed
and stewardship strengthened, sending also a strong
message to the community about the government
commitment with its implementation in the context of
the national policy for cervical cancer prevention.
The study showed increased screening among hard-to-
reach women compared to what was attained the year
previous to the scaling-up. It is possible that part of the
population tested with clinician-collected tests were
women offered self-collection by CHWs who preferred to
get screened at health centers. This was observed in the
RCT of the EMA study, where 15% of women contacted
by CHWs preferred clinician-collected tests [9]. However,
our study design did not allow measuring the impact of
offering HPV self-collection on screening performed at
health centers. It is neither possible to know if women
reached by HPV self-collection would have eventually
been screened at health centers, but in any case, the
strategy is at least advancing the date of screening of these
women. It is possible as well that the women reached by
self-collection would have never been screened at all.
Evidence shows that under-screened women have a higher
risk of developing cervical cancer [33]. In addition, women
with public health coverage are a socially vulnerable popu-
lation, with over-representation among women with
cervical cancer in Argentina [34]. If the strategy is main-
tained, and its pace, 80% of these hard-to-reach, high-risk
women, could be screened in 5 years with high potential
impact on cervical cancer control among this population.
Adoption has been described as the intention to
employ an innovation or evidence-based practice [35].
Our study showed an adequate level of adoption of
the strategy by CHWs, with 69% of trained CHWs
with a self-collected test registered in SITAM. This is
probably an under-estimation of the level of adoption
as some CHWs might have adopted the strategy with-
out being successful in the offer of self-collection, due
to women characteristics or circumstances beyond
his/her control. That is also a possible explanation to
the fact that when we analyze the percentage of
CHWs with at least one self-collected sample in the
target population, the figure drops to 62%. Most CHWs
were satisfied with offering the strategy. A qualitative
study on CHWs’ experiences about HPV self-collection
[13] showed that the possibility of having an active role
in cervical cancer prevention activities was a main mo-
tivation factor for CHWs.
The implementation dimension in the RE-AIM model
refers to the extent to which a program is delivered as
intended [16]. In our study, training was delivered to the
vast majority of CHWs, and there were almost no
discarded samples at the laboratory. Few problems were
reported with provision of self-collection materials.
Availability of these supplies has a direct impact on the
possibility of offering the test, and therefore, an interrup-
tion in their provision must be closely monitored. Find-
ing a low frequency of reported issues was considered
particularly important, as problems in access to inputs
essential to CHWs provision of health services can
negatively affect their work [36].
High coverage will not result in a decrease of disease
burden if women are not diagnosed/treated. The protocol
for scaling-up of self-collection recommended cytology as
the triage test. Still there were 14 HPV+ women who had
colposcopy without a previous cytology, revealing a prob-
lem of adherence to the triage protocol which has also
been found in another study [3]. In our study, 77.5% of
HPV+ women had follow-up procedures. Compliance
with triage is lower than in the EMA RCT [9] and in a
Chilean study [7] where 86% of women had colposcopic
referral after an HPV positive test. However, the scaling-
up protocol included a visit for cytology triage, an
additional step not included in the EMA study. In a study
carried out in France among non-attenders of low socio-
economic level, 41% of women had a Pap smear after a
positive HPV self-collected test [37]. Adding a visit to
under-screened women poses a problem, as very probably
the barriers faced by women to get screened at health
centers [38, 39] partly account for the loss to cytology
triage. This underscores a major limitation of self-
collection followed by cytology. The protocol in place at
health centers for clinician-collected samples states that
HPV tests and Pap smears must be taken at the same time
[17], but this is not possible in a self-collection context.
Among women with self-collected tests, CIN2+ detection
rate was 0.9%. This rate is lower than the one reported in
the literature [5], and specifically in the EMA RCT [9],
most probably due to the loss to follow-up, both at triage
and colposcopic diagnosis.
Our study has a main limitation. We were not able to
measure how many women were contacted by CHWs;
therefore, we cannot evaluate how successful they were in
the offer of self-collection. When we compare the average
number of self-collected samples per CWH reported in the
EMA RCT with the average obtained during scaling-up of
the strategy, we observe that the figure drops (11 vs. 30).
This decrease can be explained by several factors. On the
one hand, the EMA study included only CHWs with good
evaluation scores, whereas scaling-up was implemented
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with incorporation of all CHWs, independent of their per-
formance scores. Including less-motivated CHWs might
have had an impact in the strategy. Also, in the EMA RCT,
women at home during the CHW visit were offered self-
collection irrespective of their past Pap screening history,
whereas in the scaling-up, CHWs were asked to offer self-
collection to under-screened women with public health
coverage. Women who were not at home during the CHW
visit could not be offered the strategy, as CHWs visit houses
once per round. Besides, the question on satisfaction in the
SEAQ was only answered by 61% of CHWs; therefore, the
reported level of satisfaction could be biased.
Conclusions
We showed that HPV self-collection offered by CHWs at
home visits can be adequately scaled-up in programmatic
conditions to increase screening of hard-to-reach women.
The strategy had a high level of adoption among CHWs,
and there were few implementation problems at the
screening phase, but obstacles for follow-up and treat-
ment. It is important to devise new strategies and tests to
increase triage and diagnosis among HPV+ women. This
study provides key evidence for countries and programs
planning to incorporate and expand HPV self-collection.
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